National Allergy Centre of Excellence

What National Allergy Centre of Excellence does

National Allergy Centre of Excellence (NACE) is Australia's federally funded peak allergy research body, established in August 2022 with a $26.9 million Australian Government grant and supplemented by an additional $14.6 million federal commitment announced in April 2025. Hosted at Murdoch Children's Research Institute (MCRI) in Melbourne, NACE coordinates an Australia-wide network of 500+ allergy researchers and clinicians organised across four research streams — drug, food, insect, and respiratory allergy — and four programmatic pillars: Transforming Allergy Care, BioRepository & Discovery, Evidence & Translation, and Training & Innovation. The organisation was recognised in June 2025 as a European Academy of Allergy and Clinical Immunology (EAACI) Advanced Research Centre, positioning it among the largest allergy research initiatives globally.

NACE's product surface combines research infrastructure platforms with clinical programs and knowledge-translation tools. Infrastructure platforms include the NACE Allergy BioRepository (ALBI) digital platform for consolidating national allergy data and biospecimens, a Clinical Trials Network providing one-stop trial start-up support, the Allergy Studies Directory listing of recruiting trials, the Living Evidence Collection for continuous global evidence synthesis, the Population Health Research Program, and the Acute Allergy Registry. Clinical programs include the world-first ADAPT OIT Program for infant peanut allergy delivered through 10 paediatric hospitals across five states, the NACE Food Allergy Biobank at The Royal Children's Hospital, and an Endorsement Scheme for member-led studies. Professional offerings include Knowledge Sharing, Seminars & Workshops (including the bi-annual NACE Symposium), and Scholar Conference Grants of up to $4,000.

The business model is grant-funded non-profit operations rather than commercial revenue. All services to families, researchers, and hospitals are delivered free of charge; the ADAPT OIT clinical program is provided at no cost to eligible infants and is funded by participating hospitals, while NACE itself is funded by Australian Government appropriations channelled through MCRI. Customer engagement is split across three primary stakeholder groups: families of infants with food allergy (end beneficiaries of clinical programs), allergy researchers and clinicians (members of the network who use infrastructure platforms), and consumers with lived experience (who shape research through the Consumer Advisory Group and Consumer Engagement Register). Distribution occurs through institutional partnerships with tertiary hospitals, general practice and allergy clinics, universities, ASCIA, Allergy & Anaphylaxis Australia (via the co-funded National Allergy Council), and international bodies including EAACI, the World Allergy Organization, and the International Network of Antibiotic Allergy Nations (iNAAN).

Name

National Allergy Centre of Excellence

Legal name

National Allergy Centre of Excellence

Website

https://nace.org.au

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

National Allergy Centre of Excellence (NACE) is Australia's federally funded peak allergy research body, hosted at Murdoch Children's Research Institute. It coordinates a 500+ researcher network across drug, food, insect, and respiratory allergy streams to deliver biorepositories, clinical trials infrastructure, and consumer-centred clinical programs.

Ownership category

akta.pro rank

Product category

Allergy Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Allergy Immunotherapy Biologics (allergen extracts, desensitization) (HLAAAEAI), Autoimmune & Allergy Diagnostics (HLAAALAK), Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT) (HLAKAAAL)

Keywords

• Allergy research
• Clinical trials network
• Biorepository services
• Living evidence
• Food allergy treatment

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

1. Government Funding: NACE was established through $26.9 million Australian Government investment in August 2022. Additional federal commitments of $14.6 million announced in April 2026. NACE operates as a federal government-funded research centre.

Pricing tiers

Go-to-market motion3 records

Distribution channels7 records

Marketing channels13 records

Core offering

NACE coordinates Australia's national allergy research infrastructure across drug, food, insect, and respiratory allergies through four pillars: Transforming Allergy Care, BioRepository & Discovery, Evidence & Translation, and Training & Innovation. It delivers clinical programs (such as the ADAPT OIT peanut allergy immunotherapy), operates digital research platforms (ALBI, Clinical Trials Network, Allergy Studies Directory, Living Evidence Collection), and runs the Food Allergy Biobank. All offerings are provided free of charge, funded by the Australian Government.

Product overview

The National Allergy Centre of Excellence (NACE) operates as Australia’s peak allergy research body, structured around four interconnected pillars: Transforming Allergy Care, BioRepository and Discovery, Evidence and Translation, and Training and Innovation. The organization functions as a platform-plus-services model, combining research infrastructure platforms (NACE Allergy BioRepository/ALBI, Clinical Trials Network, Allergy Studies Directory, Living Evidence Collection, Population Health Research Program) with clinical programs (ADAPT OIT Program, Food Allergy Biobank, Acute Allergy Registry) and professional development offerings (Endorsement Scheme, Knowledge Sharing, Seminars & Workshops, Scholar Conference Grants). These offerings are unified by a network of over 500 allergy researchers across four allergy streams (drug, food, insect, respiratory) working within a digital health infrastructure to accelerate allergy research and translate evidence into improved consumer care.

Differentiator

Problem solved

Functional benefit

Brands

• ADAPT OIT Program: World's first national standardised model of care for treating peanut allergy in babies through oral immunotherapy
• ALBI (NACE Allergy BioRepository)
• NACE Clinical Trials Network
• Living Evidence Collection
• Population Health Research Program
• Allergy Studies Directory
• Acute Allergy Registry
• NACE Food Allergy Biobank
• SNAPR (Setting National Allergy Priorities for Research)

Products and services

• ADAPT OIT Program World's first standardised national model of care for treating peanut allergy in babies through oral immunotherapy, offered at ten paediatric hospitals across five Australian states with NACE evaluation study. Provided free of charge to eligible children under 12 months with peanut allergy.
• NACE Allergy BioRepository (ALBI) A national digital platform using cutting-edge technology to securely consolidate and integrate allergy data and biospecimens from NACE-led and endorsed allergy studies, enabling researchers to harness big data analysis for allergy prevention, diagnosis, and management.
• Food Allergy Biobank A nationally significant resource collecting blood and saliva samples from children attending The Royal Children's Hospital Allergy Clinic to support research into new biological markers and improved diagnostic methods for food allergies.
• Clinical Trials Network A national one-stop-shop to fast-track startup of allergy trials, providing site identification, budget guidance, connections to collaborators, and practical resources including templates and ethics submission guidelines.
• Allergy Studies Directory A comprehensive listing platform of drug, food, insect and respiratory allergy studies currently recruiting or underway across Australia, enabling individuals and families to subscribe to email updates.
• Living Evidence Collection Continuous surveillance and rapid synthesis platform providing living systematic reviews on priority allergy topics including penicillin allergy delabelling, food allergy prevention, and tick-borne allergic conditions. Results are regularly updated and openly available through Open Science Framework.
• Population Health Research Program Program that maps allergic disease prevalence and distribution across Australia, turning big data into targeted action and setting the first consumer-centred National Allergy Research Agenda.
• Acute Allergy Registry A purpose-built digital registry capturing data from patients presenting at participating Victorian hospital emergency departments with acute allergic reactions or anaphylaxis to improve understanding and clinical management.
• Endorsement Scheme A framework for endorsing member-led allergy research to encourage collaboration, advocate for high research standards, and enhance competitiveness for grant applications.
• Knowledge Sharing Platform Platform raising domestic and international awareness of Australian allergy research through national events, webinars, publications directory, and coordination of allergy advocacy programs.
• Seminars & Workshops In-person and virtual events including bi-annual NACE Symposium, Annual NACE-CFAR Training Day, Annual Stream Meetings, and ASCIA-NACE HotPubs sessions for collaboration and knowledge exchange.

Quantifiable outcome

• 8.2 million Australians affected by allergic disease; $18.9 billion financial cost annually
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

25 partnerships are on record, tiered core, major and minor.

• National Allergy Council (NAC)coreStrategic or Co-development Partner · 1 January 2022NAC is a partnership between ASCIA and Allergy & Anaphylaxis Australia. NACE and NAC were funded together by Australian Government in 2022 to transform allergy research and clinical care. Working alongside NAC, NACE ensures healthcare services, public health programs and clinical guidelines stay focused on latest evidence.
• Murdoch Children's Research Institute (MCRI)coreStrategic or Co-development PartnerNACE is hosted at MCRI in Melbourne's biomedical precinct. MCRI provides institutional infrastructure and hosts the Centre for Food Allergy Research (CFAR) which forms the NACE Food Allergy Stream.
• Centre for Food Allergy Research (CFAR)coreStrategic or Co-development PartnerNHMRC-funded centre hosted at MCRI. Members of CFAR make up the NACE Food Allergy Stream, providing the core research foundation for food allergy initiatives including ADAPT OIT Program.
• Australasian Society of Clinical Immunology and Allergy (ASCIA)coreStrategic or Co-development PartnerPeak medical body partnering with Allergy & Anaphylaxis Australia in the National Allergy Council. ASCIA collaborates with NACE on living evidence collection, clinical guidelines including penicillin allergy delabelling and food allergy prevention guidelines.
• Allergy & Anaphylaxis Australia (A&AA)coreStrategic or Co-development PartnerPeak patient support organisation partnering with ASCIA in the National Allergy Council. A&AA collaborates on consumer engagement and awareness initiatives.
• International Network of Antibiotic Allergy Nations (iNAAN)coreStrategic or Co-development PartnerNACE partners with iNAAN to scale the penicillin allergy delabelling network of 47 hospitals and support further research through sharing of data with NACE Allergy BioRepository (ALBI). Joint iNAAN-Kids study rolling out paediatric digital antibiotic allergy toolkit.
• European Academy of Allergy and Clinical Immunology (EAACI)majorStrategic or Co-development PartnerNACE was recognised as an EAACI Advanced Research Centre in June 2025, acknowledging exemplary standards in allergy research, healthcare quality, and education. EAACI is a major global allergy organisation providing international collaboration opportunities.
• Queensland University of Technology (QUT)coreStrategic or Co-development PartnerQUT Allergy Research Group, led by Professor Janet Davies (NACE Pillar 2 Lead), contributes to respiratory allergy research and the ALBI biorepository platform development. Universities and partners supporting Pillar work and PhD Scholars.
• University of QueenslandcoreStrategic or Co-development PartnerUQ's Child Health Research Centre hosts researchers including A/Prof Jennifer Koplin (NACE Pillar 3 Lead) and contributes to food allergy epidemiology research.
• University of MelbournecoreStrategic or Co-development PartnerMultiple NACE-affiliated researchers including Professor Kirsten Perrett hold honorary positions. Partnership on Red Imported Fire Ants Study and various research initiatives.
• University of New South WalescoreStrategic or Co-development PartnerContributes to insect allergy research including Professor Tony Basten (International Scientific Advisory Board) and Hongkai Tan (PhD Scholar on tick-induced allergies).
• University of AdelaidecoreStrategic or Co-development PartnerHosts Dr Shweta Mhatre (NACE Insect Allergy PhD Scholar) studying venom immunotherapy diagnostics. Partnership on insect allergy research.
• Western Sydney UniversitycoreStrategic or Co-development PartnerHosts Dr Joshua Jacob (NACE Respiratory Allergy PhD Scholar) studying patient perspectives in allergic rhinoconjunctivitis and allergen immunotherapy.
• University of SydneycoreStrategic or Co-development PartnerHosts Professor Dianne Campbell (NACE Pillar 4 Lead) and contributes to training and innovation programs for allergy researchers.
• University of Western AustraliacoreStrategic or Co-development PartnerHosts Dr Michael O'Sullivan (NACE Food Allergy Stream Co-chair) and Dr Sandra Salter (Postdoctoral Fellow). Partnership on food allergy research.
• Australian Clinical Trials AllianceminorStrategic or Co-development PartnerNACE is an Associate Member. ACTA provides resources library supporting investigator-led clinical trials that NACE leverages for Clinical Trials Network.
• World Allergy OrganizationminorStrategic or Co-development PartnerInternational organisation collaborating on global allergy awareness and research initiatives.
• Tick Induced Allergies Research & Awareness (TIARA)minorStrategic or Co-development PartnerCo-chaired by Professor Tony Basten (NACE International Scientific Advisory Board). Collaboration on insect allergy research and tick-induced allergies.
• Melbourne Children's LifeCoursecoreStrategic or Co-development PartnerCollaboration on Allergy Studies Metadata Platform to improve discoverability of allergy studies for secondary research.
• Australian Living Evidence Collaboration (ALEC)coreStrategic or Co-development PartnerPartnership supporting living evidence approaches in allergy research and rapid evidence synthesis.
• The Royal Children's Hospital MelbournecoreStrategic or Co-development PartnerMajor hospital partner hosting the Food Allergy Biobank and Acute Allergy Registry. Home to Professor Kirsten Perrett (NACE Director) as Paediatric Allergist. Key site for ADAPT OIT Program.
• ADAPT OIT Program Participating HospitalscoreStrategic or Co-development PartnerTen paediatric tertiary hospitals across five states (The Royal Children's Hospital VIC, Queensland Children's Hospital QLD, Royal Prince Alfred Hospital NSW, Sydney Children's Hospital NSW, Children's Hospital at Westmead NSW, John Hunter Children's Hospital NSW, Campbelltown Hospital NSW, Women's and Children's Health Network SA, Perth Children's Hospital WA, Fiona Stanley Hospital WA) delivering world-first national peanut oral immunotherapy program.
• Asthma Foundations of AustraliaminorStrategic or Co-development PartnerPartnership on respiratory allergy research and advocacy initiatives.
• Asthma and Respiratory Foundation of New ZealandminorStrategic or Co-development PartnerTrans-Tasman collaboration on respiratory allergy research and awareness.
• Queensland Cyber Infrastructure Foundation (QCIF)coreTechnology or IntegrationProvides digital infrastructure support for allergy research data platforms and ALBI biorepository systems.

Scale indicators16 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Centre for Food Allergy Research (CFAR): NHMRC-funded Centre of Research Excellence hosted at MCRI whose members form the NACE Food Allergy Stream. Directly comparable as an Australian food allergy research network co-located with NACE and sharing investigators and infrastructure.
• Australasian Society of Clinical Immunology and Allergy (ASCIA): Peak professional medical body for clinical immunology and allergy in Australia/New Zealand. Comparable as the national allergy clinical and education authority that co-runs the National Allergy Council with NACE.
• Food Allergy Research & Education (FARE): US-based leading patient advocacy and research funding organisation for food allergy. Comparable as a national centre driving food allergy research, patient engagement, and policy at scale.
• Allergy & Anaphylaxis Australia (A&AA): Australian peak patient support organisation partnering with ASCIA in the National Allergy Council alongside NACE. Comparable as a national allergy consumer-voice and education body.
• European Centre for Allergy Research Foundation (ECARF): European foundation certifying allergy excellence and running multi-site research and clinical networks. Comparable as an international centre-of-excellence platform model for allergy research.

Broad incumbents

• European Academy of Allergy and Clinical Immunology (EAACI): Largest European professional allergy organisation, which granted NACE Advanced Research Centre status. Comparable as a broader international incumbent setting allergy research, education, and guideline standards.
• American Academy of Allergy, Asthma & Immunology (AAAAI): Major US professional allergy society with extensive research, training, and guideline-setting functions. Comparable as a large incumbent allergy research and clinical authority operating in a different geography.
• Murdoch Children's Research Institute (MCRI): Host institution of NACE and one of Australia's largest pediatric research institutes. Comparable as a parent organisation providing allergy, infectious disease, and child health research infrastructure at national scale.

Regional players

• Allergy UK: Leading UK patient allergy charity providing information, support, and advocacy. Comparable as a national allergy consumer-organisation in a different geography.
• Asthma and Respiratory Foundation of New Zealand: Trans-Tasman respiratory health organisation partnered with NACE on respiratory allergy research. Comparable as a regional respiratory/allergy advocacy and research partner in New Zealand.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/NACEresearch
• LinkedInlinkedin.com/company/naceresearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Allergy Centre of Excellence